Insiders Prime Medicine, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 00:37:27 12/06/2026 HKT			5-day change	1st Jan Change
2.785 ^USD	+2.77%		-20.03%	-20.03%

06-11	Prime Medicine, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-10-2026 10:40 AM
06-06	Prime Medicine, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-04-2026 12:50 PM

04-16	Prime Medicine, Inc. Announces Executive Changes, Effective April 16, 2026	CI
11-04	Prime Medicine, Inc. Appoints Matthew Hawryluk as Chief Business Officer	CI
16/07/25	Prime Medicine, Inc. Announces Step Down of Jeremy Duffield as Chief Scientific Officer, Effective July 15, 2025	CI
19/05/25	Prime Medicine to Cut Costs, Focus on Liver Treatment Programs; New CEO Named	MT
19/05/25	Prime Medicine Announces Strategic Restructuring To Focus On Opportunities In Large Genetic Liver Diseases, Cystic Fibrosis, And Partnered Programs Alongside CEO Leadership Transition	RE
19/05/25	Prime Medicine, Inc. Announces CEO Changes	CI
19/05/25	Prime Medicine, Inc. Announces Board Changes	CI
05/01/24	Prime Medicine Names Foghorn Therapeutics' CFO to be its New Finance Chief	MT
05/01/24	Prime Medicine, Inc. Announces Executive Changes, Effective January 17, 2024	CI
03/06/23	Insider Sell: Prime Medicine	MT
11/05/23	Prime Medicine, Inc. Appoints Jeff Marrazzo to Its Board of Directors	CI
27/10/22	Insider Buy: Prime Medicine	MT
27/10/22	Insider Buy: Prime Medicine	MT